Mechanisms of transcellular transport of wheat germ agglutinin-functionalized polymeric nanoparticles in Caco-2 cells.
暂无分享,去创建一个
Meng Huang | Xinguo Jiang | Lei Yao | Quanyin Hu | Jun Chen | Qin Lu | Q. Lu | Quanyin Hu | Xin-guo Jiang | Xiaoling Gao | L. Yao | Jun Chen | Hongzhuan Chen | Qingxiang Song | Meng Huang | Bingxian Wu | H. Qi | Zheng-xing Rong | Xiaoling Gao | Qingxiang Song | Hongzhuan Chen | Bingxian Wu | Hong Qi | Zhengxing Rong | Xiaoling Gao
[1] Cui Tang,et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.
[2] D. Begley,et al. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[3] P. van der Sluijs,et al. rab4 Regulates Transport to the Apical Plasma Membrane in Madin-Darby Canine Kidney Cells* , 2002, The Journal of Biological Chemistry.
[4] W. Lu,et al. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. , 2006, Cancer research.
[5] M. Holl,et al. The mechanism of polyplex internalization into cells: testing the GM1/caveolin-1 lipid raft mediated endocytosis pathway. , 2010, Molecular pharmaceutics.
[6] Xin-guo Jiang,et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. , 2011, Biomaterials.
[7] Xin-guo Jiang,et al. Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles. , 2008, Biochemical and biophysical research communications.
[8] Samuel A Wickline,et al. Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery. , 2008, Biomaterials.
[9] W. Saltzman,et al. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. , 2009, Biomaterials.
[10] C. Tsilfidis,et al. PEG-PLA microparticles for encapsulation and delivery of Tat-EGFP to retinal cells. , 2010, Biomaterials.
[11] Yi Han,et al. Predicting Caco-2 Cell Permeation Coefficients of Organic Molecules Using Membrane-Interaction QSAR Analysis , 2002, J. Chem. Inf. Comput. Sci..
[12] Michael Wirth,et al. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. , 2004, Advanced drug delivery reviews.
[13] Xin-guo Jiang,et al. The association of autophagy with polyethylenimine-induced cytotoxicity in nephritic and hepatic cell lines. , 2011, Biomaterials.
[14] P. Opanasopit,et al. In vitro Permeability Enhancement in Intestinal Epithelial Cells (Caco-2) Monolayer of Water Soluble Quaternary Ammonium Chitosan Derivatives , 2010, AAPS PharmSciTech.
[15] H. Takeuchi,et al. In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[16] A. Jones,et al. Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics II. Identification of endosomal and lysosomal compartments in HepG2 cells combining single-step subcellular fractionation with fluorescent imaging , 2007, Journal of drug targeting.
[17] I. Alves,et al. Cell biology meets biophysics to unveil the different mechanisms of penetratin internalization in cells. , 2010, Biochimica et biophysica acta.
[18] W. Shen,et al. Accumulation of transferrin in Caco-2 cells: a possible mechanism of intestinal transferrin absorption. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[19] G. Berger,et al. Glycoconjugate Expression in Normal Human Inferior Turbinate Mucosa: A Lectin Histochemical Study , 2005, American journal of rhinology.
[20] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[21] R. Narain,et al. The effect of polymer architecture, composition, and molecular weight on the properties of glycopolymer-based non-viral gene delivery systems. , 2011, Biomaterials.
[22] Tilen Koklic,et al. Impact of membrane properties on uptake and transcytosis of colloidal nanocarriers across an epithelial cell barrier model. , 2010, Journal of pharmaceutical sciences.
[23] Zhiqiang Yan,et al. Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[24] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[25] Jayanth Panyam,et al. Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] J. Benoit,et al. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. , 2010, Biomaterials.
[27] Kai Simons,et al. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway , 1992, Cell.
[28] Leaf Huang,et al. Pharmacokinetics and biodistribution of nanoparticles. , 2008, Molecular pharmaceutics.
[29] Tejal A Desai,et al. PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium. , 2012, Biomaterials.
[30] J. Benoit,et al. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[31] Wei Lu,et al. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. , 2006, Biomaterials.
[32] Xin-guo Jiang,et al. Effect of wheat germ agglutinin density on cellular uptake and toxicity of wheat germ agglutinin conjugated PEG-PLA nanoparticles in Calu-3 cells. , 2011, International journal of pharmaceutics.
[33] J. Benoit,et al. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. , 2010, Nanomedicine.
[34] Marino Zerial,et al. Rab proteins as membrane organizers , 2001, Nature Reviews Molecular Cell Biology.
[35] S. Sant,et al. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles. , 2008, Journal of biomedical materials research. Part A.
[36] S. Hamm-Alvarez,et al. Tyrphostin A8 stimulates a novel trafficking pathway of apically endocytosed transferrin through Rab11-enriched compartments in Caco-2 cells. , 2008, American journal of physiology. Cell physiology.
[37] J. Kopeček,et al. Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristics. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[38] D. Balding,et al. HLA Sequence Polymorphism and the Origin of Humans , 2006 .
[39] A. Wandinger-Ness,et al. Rab proteins and endocytic trafficking: potential targets for therapeutic intervention. , 2003, Advanced drug delivery reviews.
[40] Lan Ma,et al. Phosphorylation state of mu-opioid receptor determines the alternative recycling of receptor via Rab4 or Rab11 pathway. , 2008, Molecular endocrinology.
[41] B. Deurs,et al. Rab7: a key to lysosome biogenesis. , 2000, Molecular biology of the cell.
[42] Huibi Xu,et al. Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. , 2011, Biomaterials.
[43] R. Langer,et al. Drug delivery and targeting. , 1998, Nature.
[44] Michael J Rust,et al. Ligands for Clathrin-Mediated Endocytosis Are Differentially Sorted into Distinct Populations of Early Endosomes , 2006, Cell.
[45] Wei Chen,et al. Rab11 is required for trans-golgi network-to-plasma membrane transport and a preferential target for GDP dissociation inhibitor. , 1998, Molecular biology of the cell.
[46] Surya Singh. Nanomedicine-nanoscale drugs and delivery systems. , 2010, Journal of nanoscience and nanotechnology.
[47] H. McBride,et al. The Rab5 effector EEA1 is a core component of endosome docking , 1999, Nature.
[48] V. Protasenko,et al. Experimental determination of the absorption cross-section and molar extinction coefficient of CdSe and CdTe nanowires. , 2006, The journal of physical chemistry. B.
[49] M. Wirth,et al. Lectin-mediated drug delivery: binding and uptake of BSA-WGA conjugates using the Caco-2 model. , 2002, International journal of pharmaceutics.
[50] Brian Storrie,et al. Capacity of the Golgi apparatus for cargo transport prior to complete assembly. , 2006, Molecular biology of the cell.
[51] L. Lim,et al. Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells. , 2004, Journal of pharmaceutical sciences.
[52] A. Abulrob,et al. Integrated platform for brain imaging and drug delivery across the blood-brain barrier. , 2011, Methods in molecular biology.
[53] M. Barbieri,et al. Role of Rab5 in insulin receptor-mediated endocytosis and signaling. , 2006, Archives of biochemistry and biophysics.
[54] Chunxiao Wang,et al. Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells. , 2010, International journal of pharmaceutics.
[55] Xinguo Jiang,et al. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[56] M. Zegers,et al. Actin filaments and microtubules are involved in different membrane traffic pathways that transport sphingolipids to the apical surface of polarized HepG2 cells. , 1998, Molecular biology of the cell.